Loading clinical trials...

Acceptance and Commitment Therapy for Religious OCD | Clinical Trials | Clareo Health

RECRUITINGNA

Acceptance and Commitment Therapy for Religious OCD

Efficacy of Acceptance and Commitment Therapy on Religiously Oriented Obsessive-Compulsive Disorder

NCT06647589•University of Alabama at Birmingham

Summary

The purpose of the study is to examine the effects and feasibility of a specific form of psychotherapy, acceptance and commitment therapy (ACT), on religiously oriented obsessive and compulsive disorder (OCD).

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•18 years old
•Meet cutoff scores for scrupulosity

Exclusion Criteria

•Presence of psychotic symptoms within six months of screening
•Current suicidal/homicidal plan/intent and/or a suicide/homicide attempt within 6 months of screening
•Non-suicidal self-injury within 6 months of screening
•Narcotics use within 3 months of screening
•Purging/restricting behavior within 3 months of screening.

Locations (1)

University of Alabama at Birmingham

Birmingham, Alabama, United States

Key Dates

Start Date

July 30, 2025

Primary Completion Date

September 1, 2026

Completion Date

September 1, 2026

Last Updated

March 19, 2026

Enrollment

ESTIMATED participants

Conditions

Obsessive-Compulsive Disorder (OCD)

Interventions

Acceptance and Commitment Therapy

BEHAVIORAL

Contacts

David Johnson

CONTACT

8013891733 dajohns4@uab.edu

Nicholas Borgogna, PhD

CONTACT

7579693677 borgogna@uab.edu

Feasibility of Modulating Cognitive Control in OCD

NCT07419009

Obsessive-Compulsive Disorder (OCD)

View study

COMPLETEDNA

Impact of EsTOCma on OCD Family Members

NCT06616350

Obsessive-Compulsive Disorder (OCD)

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 19, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions